Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 18 di 18
Titolo Data di pubblicazione Autore(i) File
Leptomeningeal enhancement analysis in diagnostic clinical setting 2015 Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 2017 Mariottini, A; Forci, B; Magnani, E; Massacesi, L; Repice, A
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 2017 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L; Repice, A
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 2017 Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L
Bilateral isolated facial palsy with fast recovery in infectious mononucleosis 2017 Forci, Benedetta; Novelli, Alessio; Sodero, Alessandro; Sorbi, Sandro
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 2017 Forci, B; Mariottini, A; Mechi, C; Massacesi, L; Repice, A.
The Central Vein Sign identifies patients diagnosed with multiple sclerosis probably carrying different diseases and showing milder disease course 2019 Azzolini, F; Grammatico, M; Carlucci, G; Goanta, L; Dallagiacoma, S; Forci, B; Barilaro, A; Repice, AM; Busto, G; Fainardi, E; Massacesi, L
MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences 2019 Azzolini, F; Grammatico, M; Carlucci, G; Goanta, L; Dallagiacoma, S; Repice, AMR; Forci, B; Dipasquale, F; Marchi, L; Fainardi, E; Massacesi, L
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 2019 Mariottini A, Innocenti C, Forci B, Magnani E, Mechi C, Barilaro A, Nistri R, Fani A, Saccardi R, Massacesi L, Repice AM.
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination 2019 Azzolini, F; Grammatico, M; Filippini, S; Carlucci, G; Repice, AM; Forci, B; Dallagiacoma, S; Busto, G; Fainardi, E; Massacesi, L
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 2019 Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 2019 Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 2019 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 2021 Mariottini A.; Filippini S.; Innocenti C.; Forci B.; Mechi C.; Barilaro A.; Fani A.; Carlucci G.; Saccardi R.; Massacesi L.; Repice A.M.
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 2021 Pasca M, Forci B, Mariottini A, Mechi C, Barilaro A, Massacesi L, Repice AM.
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 2022 Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 2022 Alice Mariottini, Benedetta Forci, Elisa Gualdani, Monica Romoli, Anna Maria Repice, Alessandro Barilaro, Claudia Mechi, Luca Massacesi, Paolo Francesconi
Mostrati risultati da 1 a 18 di 18
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile